At Diplomat, we support severe combined immunodeficiency (SCID) patients through treatment, patient education and clinical expertise available 24/7. SCID treatments require immune globulin therapy to help fight off recurrent infections and bolster the immune system. We understand that while treatment is necessary, managing it can be stressful. That’s why we’re here—so patients and their caregivers have one less thing to worry about. It’s why we contact patients before every refill, coordinating delivery, monitoring side effects, answering questions and often simply listening. And it’s why we do whatever it takes to keep patients adherent and give them the resources they need to successfully manage their treatment.
Severe Combined Immunodeficiency
One of the first steps after a severe combined immunodeficiency (SCID) diagnosis is understanding the condition. The information on this site and linked sites is not meant to replace your physician’s advice, medical care or a diagnosis. If you have questions about your disease, please ask your prescriber.
Severe combined immunodeficiency is an extremely rare disease, occurring in about one in a million people. Commonly known as “bubble boy” disease, SCID is caused by a genetic predisposition that leaves babies without B or T cells, making even the common cold a life-threatening illness.
New therapies have brought hope to patients with SCID. If screened and treated properly, it is possible for patients to live normal and healthy lives. Scientists continue to research new methods to treat SCID, but immune globulin therapy and—to a greater extent—bone marrow transplants have demonstrated success.
The information contained herein may not be construed as medical advice. It is for educational purposes only. Diplomat Pharmacy Inc. takes no responsibility for the accuracy or validity of the information contained herein, nor the claims or statements of any manufacturer.